Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Grossman

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Advances in Radiation Oncology|October 30, 2018
Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvageColette J Shen, Megan N Kummerlowe, Kristin J Redmond, et al.
Journal of Neuro-Oncology|November 24, 2019
Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximabFayez Estephan, Xiaobu Ye, Omar Dzaye, et al.
Journal of Neuro-Oncology|June 14, 2015
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomasJian L Campian, Xiaobu Ye, Douglas E Gladstone, et al.
Journal of Neuro-Oncology|October 18, 2019
White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximabFayez Estephan, Xiaobu Ye, Omar Dzaye, et al.
Journal of Neurosurgery|December 3, 2008
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiformeMatthew J McGirt, Khoi D Than, Jon D Weingart, et al.
Journal of Neuro-Oncology|August 20, 2015
Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomasJaishri O Blakeley, Stuart A Grossman, Tom Mikkelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Phase I and correlative biology study of cilengitide in patients with recurrent malignant gliomaL Burt Nabors, Tom Mikkelsen, Steven S Rosenfeld, et al.
Fluids and Barriers of the CNS|January 16, 2018
The effect of an adenosine A<sub>2A</sub> agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastomaSadhana Jackson, Jon Weingart, Edjah K Nduom, et al.
American Journal of Clinical Oncology|May 8, 2013
The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic AdenocarcinomaAaron T Wild, Xiaobu Ye, Susannah G Ellsworth, et al.
Journal of Neurosurgery|August 20, 2003
An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trialStephen B Tatter, Edward G Shaw, Mark L Rosenblum, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Advances in Radiation Oncology|October 30, 2018
Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvageColette J Shen, Megan N Kummerlowe, Kristin J Redmond, et al.
Journal of Neuro-Oncology|November 24, 2019
Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximabFayez Estephan, Xiaobu Ye, Omar Dzaye, et al.
Journal of Neuro-Oncology|June 14, 2015
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomasJian L Campian, Xiaobu Ye, Douglas E Gladstone, et al.
Journal of Neuro-Oncology|October 18, 2019
White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximabFayez Estephan, Xiaobu Ye, Omar Dzaye, et al.
Journal of Neurosurgery|December 3, 2008
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiformeMatthew J McGirt, Khoi D Than, Jon D Weingart, et al.
Journal of Neuro-Oncology|August 20, 2015
Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomasJaishri O Blakeley, Stuart A Grossman, Tom Mikkelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Phase I and correlative biology study of cilengitide in patients with recurrent malignant gliomaL Burt Nabors, Tom Mikkelsen, Steven S Rosenfeld, et al.
Fluids and Barriers of the CNS|January 16, 2018
The effect of an adenosine A<sub>2A</sub> agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastomaSadhana Jackson, Jon Weingart, Edjah K Nduom, et al.
American Journal of Clinical Oncology|May 8, 2013
The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic AdenocarcinomaAaron T Wild, Xiaobu Ye, Susannah G Ellsworth, et al.
Journal of Neurosurgery|August 20, 2003
An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trialStephen B Tatter, Edward G Shaw, Mark L Rosenblum, et al.
Pageof 18